Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology.

IMB Partners (IMB) is a private equity independent sponsor focused on making control acquisitions and partnering with management teams to grow lower middle-market companies serving government agencies and electric and gas utilities.

Mast Reforestation built the only vertically integrated solution to reforest the growing pool of millions of acres that have been damaged by wildfire.

Northrim Horizon is a private equity firm that acquires well-run, profitable business services, software and tech-enabled services, and healthcare services businesses with the intent to own those businesses indefinitely. Northrim builds long-term value by reinvesting its earnings into its people, processes and technology.